Get In Touch

Infertility can be defined as the inability of an individual to reproduce by natural means. The causes of infertility are extremely diverse. It can be due to advancement of maternal age, disorders in the occurrence of ovulation, tubal occlusion or blockage, genetics, sexually transmitted infections, immune infertility, endometrial polyps, uterine fibroids, infertility due to male factors, endometriosis, and others. According to CDC, in the U.S., 1 in every 8 couples or approximately 12% of married women face complications to attain pregnancy. Around one third infertility cases are due to the female partner, another one third due to the male counterpart, and the remaining are attributed to both the partners or other unexplained infertility causes. Fertility rate has halved since 1960. Treatment options for infertility include education or spreading awareness, medications to assist the development of egg during the ovulation period, insemination, in vitro fertilization (IVF), and third party reproduction surgery.

Increase in the number of cases of infertility can be attributed to rise in physical inactivity, continual shift toward sedentary lifestyle, improper fetal care, delayed pregnancy, smoking, excessive consumption of alcohol, stress, and others. Moreover, rise in prevalence of diabetes and obesity is the key factor contributing to the increase in rate of these conditions. Surge in the number of fertility clinics across the world coupled with advancement in technologies to treat infertility among both men and women drives the global infertility treatment market. Furthermore, increase in investments by the public and private sectors in the health care industry has led to a conducive environment for the growth of the global infertility treatment market. However, high cost of procedures associated with reproductive techniques and other factors such as decreased efficacy among elderly women are likely to be major restraints of the global infertility treatment market in the next few years.

The global infertility treatment market can be segmented based on product, procedure, patient type, end-user, and region. In terms of product, the infertility treatment market can be classified into equipment, media & consumables, and accessories. The equipment segment can be categorized into microscopes, sperm analyzer systems, imaging systems, micromanipulators systems, ovum aspiration pumps, cryosystems, incubators, gas analyzers, and laser systems. Based on procedure, the global infertility treatment market can be divided into assisted reproductive technology, artificial insemination, fertility surgery, and others. The assisted reproductive technology segment can be classified into in vitro fertilization, surrogacy, and intra-cytoplasmic sperm injection (ICSI). The artificial insemination segment can be categorized into intrauterine insemination, intracervical insemination, and intratubal insemination. The fertility surgery segment can be divided into myomectomy, laparoscopy, hysteroscopy, varicocelectomy, laparotomy, tubal ligation reversal, and microsurgical reconstruction. In terms of patient type, the infertility treatment market can bifurcated into male and female. Based on end-user, the global infertility treatment market can be classified into hospitals & surgical clinics, fertility centers, research institutes, and cryobanks.

In terms of region, the global infertility treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for major share of the global infertility treatment market in terms of revenue in 2017. High growth of the infertility treatment market in the region can be attributed to increase in investments in R&D, high awareness, favorable rules & regulations and reimbursement policies by governmental bodies, increase in health care expenditure, and others. Europe accounted for significant share of the global infertility treatment market in terms of revenue in 2017. However, the market in Asia Pacific is expected to expand at a high CAGR during the forecast period. Increase in awareness and population, and rise in support in terms of investments by the public and private sectors are likely to drive the market in the region in the near future. The market in Middle East & Africa and Latin America is projected to witness moderate growth during the forecast period. Growth in these region can be attributed to evolving lifestyle, increased adoption of smoking, consumption of alcohol and increase in sedentary lifestyle.

Key players operating in the global infertility treatment market include Cook Group Incorporated, Esco Micro Pte. Ltd., Genea Limited, Hamilton Throne, Ltd., Ihmedical A/S, Irvine Scientific (A Member of Jx Holdings Group), IVFTech Aps, Kitazato Corporation, Medgyn Products, Inc., and Rocket Medical plc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Infertility Treatment Market

Pre Book